跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 77,204 条关于
“Bcl-2 protein”
全部
77,204
临床试验
49,574
药物
8,798
机构
1,456
资讯
17,376
去年
Lisaftoclax Poised to Be First Approved Bcl-2 Inhibitor in China for Chronic Lymphocytic Leukemia
2年前
Bio-Path Holdings' BP1003 Demonstrates Therapeutic Potential in Diverse Cancers
去年
Clinical Trials Target Residual Disease to Improve AML Outcomes
3个月前
BPGbio to Present Phase 2 Data on Novel Mitochondrial-Targeted Therapy BPM31510 for Glioblastoma at ASCO 2026
9个月前
RedHill's Opaganib Shows Promise in Overcoming Venetoclax Resistance in Chronic Lymphocytic Leukemia
去年
Bio-Path Holdings Expands DNAbilize Platform into Obesity and Advances Oncology Programs
去年
China's NMPA Grants Priority Review to Ascentage Pharma's Lisaftoclax for Chronic Lymphocytic Leukemia
3年前
Acalabrutinib, Obinutuzumab, and Venetoclax Triplet Shows Promise in High-Risk CLL
去年
AbbVie Enters Indian Oncology Market with Venetoclax for Blood Cancer Treatment
去年
Bio-Path Holdings Reports Clinical Progress Across Cancer Pipeline with Promising Patient Responses
第 1 页,共 1738 页
上一页
下一页